X

Vous n'êtes pas connecté

Maroc Maroc - POANDPO.COM - A La Une - 21/Mar 04:20

AstraZeneca to acquire EsoBiotec for up to $1 billion

AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity. The EsoBiotec Engineered NanoBody Lentiviral (ENaBL) platform empowers the immune system to attack cancers and could offer many more patients access to ...

Articles similaires

AstraZeneca to acquire EsoBiotec for up to $1 billion

poandpo.com - 21/Mar 04:20

AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has...

Sorry! Image not available at this time

Alumis, Kaken Pharma ink collaboration & licensing agreement to develop, manufacture and commercialize ESK─001 in dermatology in Japan

pharmabiz.com - 27/Mar 08:51

Alumis Inc, a clinical─stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and...

Sorry! Image not available at this time

Vertex launches pivotal trial for stem-cell derived islet therapy

desang.net - 26/Mar 08:02

Vertex has announced that its Phase 1/2 trial for its VX-880 stem cell-derived islet therapy is converting to a Phase 1/2/3 pivotal trial, enrolling...

CAR-T Pipeline Focus: Blood Cancers Lead the Way in Development

medindia.net - 23/Mar 15:31

Chimeric antigen receptor T-cell (CAR-T) therapy has emerged as a transformative force in cancer treatment, particularly within the realm of cell...

Sorry! Image not available at this time

IPFone Signs Definitive Agreement to Acquire TelNet Worldwide

bestproductsreview.in  - 23/Mar 21:16

IPFone, a leader in Unified Communications and Internet services, today announced the signing of a definitive agreement to acquire TelNet Worldwide,...

Sorry! Image not available at this time

IPFone Signs Definitive Agreement to Acquire TelNet Worldwide

bestproductsreview.in  - 23/Mar 21:16

IPFone, a leader in Unified Communications and Internet services, today announced the signing of a definitive agreement to acquire TelNet Worldwide,...

Sorry! Image not available at this time

NCT Alliance buys 51pct of Setara Juara for RM22mil

nst.com.my - 19/Mar 20:48

KUALA LUMPUR: NCT Alliance Bhd’s unit NCT Panorama Sdn Bhd has entered into a conditional sale of shares agreement with Herman Lee and Melvin Lee to...

Sorry! Image not available at this time

KCB Group To Acquire 75% Stake In Kenyan Fintech Firm

techguy.co.ke - 25/Mar 15:12

Riverbank Solutions Limited, founded by Nick Mwendwa, the former president of the Football Kenya Federation (FKF), specializes in developing and...

Sorry! Image not available at this time

KCB Group To Acquire 75% Stake In Kenyan Fintech Firm

techguy.co.ke - 25/Mar 15:12

Riverbank Solutions Limited, founded by Nick Mwendwa, the former president of the Football Kenya Federation (FKF), specializes in developing and...

New antibody reduces tumour growth in treatment-resistant breast and ovarian cancers

oncologynews.com.au - 20/Mar 06:44

Antibody treatment which activates the patient’s immune system against cancer, known as immunotherapy, is increasingly being investigated as an...